SOURCE: IO Circuit

September 06, 2012 13:00 ET Top Gainers and Traders on the OTC Markets: SMNG, DYNV, RVPL, CYOE

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit

NEW YORK, NY--(Marketwire - Sep 6, 2012) - offers free real-time market quotes and level II access along with breaking news from leading North American stock exchanges. MNS Quotes pre-market alert provides a heads up on top gaining and most alerted small cap stocks from the OTC and Pink Sheet markets. The most alerted OTCBB stocks we are tracking include SMNG, DYNV, RVPL, CYOE.

Strategic Mining Corp. (OTCQB: SMNG) The goal of SMNG is to become a significant explorer and developer of gold properties in Guinea and Vietnam. It is currently planning more exploration and development programs on its Siguiri property, and intends to expand its property base in Guinea by acquisition and joint venture. SMNG is up 100% with a volume of 7,663,333. See who's trading SMNG today on Level II in real-time at

Dynamic Ventures Corporation (OTCQB: DYNV) Dynamic Ventures Corporation develops and markets efficient construction solutions for residential and commercial buildings. The company offers a turnkey solution enabling the firm to custom design, manufacture and install complete LEED certified structures. DYNV is up 154.35% with a volume of 12,049,255. Check the DYNV stock price in real-time for free at

RVPLUS Inc. (OTCQB: RVPL) is in preparation to export goods purchased in a material agreement with the African government and United Nations affiliate partners for a total value of $1.8 billion over next 10 years. The Company continues to operate as a partner and supplier for American made products that reduce energy consumption and carbon emissions in facilities and transportation. RVPL is up 106.43% with a volume of 1,000. Get free real-time information on RVPL at

CytoCore, Inc. (OTCQB: CYOE) products are focused upon cervical cancer. CYOE plans to expand our focus to include other gynecological cancers as well as bladder, lung and breast cancers, among others. Within each of these markets, CYOE anticipates that the CytoCore Solutions products will be sold as individual value-added drop-in replacements for existing products and as integrated systems that improve the efficiency and effectiveness of clinical and laboratory operations. CYOE is up 77.78% with a volume of 1,946. See exclusive profile information on CYOE at

For more on what's moving in the markets and free real-time / level 2 market quotes see

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO Circuit twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.

Contact Information